Description
Indication & Scope
JiLunTai (Technetium (99mTc) Rectegatide Pecixetan Injection) is a Class 1 innovative radiopharmaceutical developed in China for SPECT imaging. It is indicated for the auxiliary examination of regional lymph node metastasis in patients with suspected lung cancer.
- Mechanism: Technetium (99mTc) Rectegatide Pecixetan is an integrin-targeted radiopharmaceutical designed for SPECT imaging.
- Drug class: Technetium-99m radiopharmaceutical diagnostic agent.
- Clinical use: Auxiliary examination of regional lymph node metastasis in patients with suspected lung cancer.
| Generic Name | Technetium (99mTc) Rectegatide Pecixetan Injection |
| Brand Name | JiLunTai® |
| Ingredient | Technetium (99mTc) Rectegatide Pecixetan |
| Dosage Form | Injection |
| Package | Polymer prefilled syringe assembly (without needle), one syringe per lead-shielded container |
| Conditions Treated | Auxiliary examination of regional lymph node metastasis in patients with suspected lung cancer |
| Taboos | Hypersensitivity to technetium (99mtc) rectegatide pecixetan or any component of the product. |
| Place of origin | China |
| Prescription type | Prescription Drug (Rx) |
| Storage Conditions | Refer to the approved package labeling. |
| Manufacturer | Foshan Radio Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20260016 |
| Date of Revision | 2026 |
| Shelf Life | Refer to the approved package labeling |
How to use ?
Recommended Dose: Administer according to the approved prescribing information.
Time: Administer before SPECT imaging as directed.
Instructions for use: For intravenous administration by qualified healthcare professionals in accordance with approved radiopharmaceutical procedures.
Interaction: Refer to the approved package labeling.
Side effects: Refer to the approved package labeling.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is JiLunTai (Technetium (99mTc) Rectegatide Pecixetan Injection)?
JiLunTai is a technetium-99m radiopharmaceutical diagnostic agent developed for SPECT imaging.
What is JiLunTai used for?
It is indicated for the auxiliary examination of regional lymph node metastasis in patients with suspected lung cancer.
How does JiLunTai work?
JiLunTai is an integrin-targeted radiopharmaceutical that enables visualization of lesions using SPECT imaging.
How is JiLunTai administered?
Administered by intravenous injection by qualified healthcare professionals before SPECT imaging.
JiLunTai® | Technetium (99mTc) Rectegatide Pecixetan | Regional Lymph Node Metastasis Assessment | DengYueRX
INN: Technetium (99mTc) Rectegatide Pecixetan
Indications: Suspected lung cancer lymph node metastasis
Dosage Form: Injection
Strength: 740–2035 MBq/mL(at calibration time)
